INCYTE CORP 4

Baker Bros.-affiliated director Julian C. Baker received equity compensation from Incyte Corporation in the form of 1,642 RSUs and 6,111 non‑qualified stock options (strike $100.64), increasing the Baker group’s already substantial indirect holdings.

On June 8, 2026, Baker Bros. Advisors LP and affiliated reporting persons, including directors Julian C. Baker and Felix J. Baker, reported routine equity compensation grants from Incyte Corporation. Julian C. Baker received 1,642 restricted stock units payable in Incyte common stock that vest in full on the earlier of June 8, 2027, the next annual shareholder meeting, or a change in control, subject to continued board service, and 6,111 non‑qualified stock options with a strike price of $100.64 per share expiring June 7, 2036. These RSUs and options, which are reported as indirectly owned by the Baker funds (667, L.P. and Baker Brothers Life Sciences LP) due to their policies and ownership structure, increase the group’s indirect equity-linked exposure but do not represent open‑market purchases or sales. After these awards, the Baker complex reports indirect beneficial ownership of approximately 28.35 million Incyte shares via one fund line, 2.83 million via another, plus direct personal and partnership holdings by Julian and Felix Baker and FBB Associates, reflecting a large, continuing aligned position.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

sec

Accession

0001193125-26-265952

Alert Tier

5